Alguwaihes Abdullah M, Alotaibi Najla, Alotaibi Metib, Masry Naglaa, Safarini Saher
Endocrinology Unit, Internal Medicine Department, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Diabetes Center, Dallah Hospital, Riyadh, Saudi Arabia.
J Diabetes Res. 2025 Jan 2;2025:4144787. doi: 10.1155/jdr/4144787. eCollection 2025.
The study was aimed at assessing the role of the MiniMed780G system of glycemic control before, during, and after Ramadan among people with Type 1 diabetes (PwT1D). This is a single-center retrospective analysis of MiniMed780G system users aged 14 years and above whose glycemic profiles were collected from February 21 to May 20, 2023, which corresponds to the Hijri months of Sha'ban, Ramadan, and Shawwal 1444/1445. Data was collected, processed, and analyzed in the framework of the Medtronic Galaxy service of the One Hospital Clinical Service (OHCS) program in Dallah Hospital, Riyadh, Saudi Arabia. Data from 43 PwT1D (24 females, mean age 30 ± 11 years with 14 ± 8 years from diabetes onset) using the MiniMed780G system were collected. Overall, the 3-month (Sha'ban, Ramadan, and Shawwal) mean sensor glucose (SG), time in range (TIR) (70-180 mg/dL), time below range (TBR) (54-69 mg/dL and < 54 mg/dL), time above range (TAR) (180-250 mg/dL and > 250 mg/dL), and glucose management indicator (GMI) showed no statistical differences within the three periods. No differences in insulin total daily dose have been detected, and no diabetic ketoacidosis (DKA) or severe hypoglycemia events occurred. The use of the MiniMed780G system is safe with favorable glycemic outcomes across nonfasting and fasting months.
该研究旨在评估美敦力780G系统在斋月前、斋月期间和斋月后对1型糖尿病患者（T1D患者）血糖控制的作用。这是一项单中心回顾性分析，研究对象为14岁及以上使用美敦力780G系统的患者，其血糖数据收集于2023年2月21日至5月20日，对应回历1444/1445年的沙班月、斋月和肖瓦尔月。数据在沙特阿拉伯利雅得达勒医院的一家医院临床服务（OHCS）项目的美敦力银河服务框架内收集、处理和分析。收集了43名使用美敦力780G系统的T1D患者（24名女性，平均年龄30±11岁，糖尿病发病时间14±8年）的数据。总体而言，3个月（沙班月、斋月和肖瓦尔月）的平均传感器葡萄糖（SG）、血糖达标时间（TIR）（70 - 180mg/dL）、血糖低于范围的时间（TBR）（54 - 69mg/dL和<54mg/dL）、血糖高于范围的时间（TAR）（180 - 250mg/dL和>250mg/dL）以及血糖管理指标（GMI）在三个时间段内均无统计学差异。未检测到胰岛素每日总剂量的差异，也未发生糖尿病酮症酸中毒（DKA）或严重低血糖事件。在非禁食和禁食月份，使用美敦力780G系统是安全的，血糖结果良好。
